ENSPRYNG

Описание товара

About ENSPRYNG

ENSPRYNG is a prescription medication used to treat neuromyelitis optica spectrum disorder (NMOSD) in adults. It contains the active ingredient satralizumab, a humanized monoclonal antibody that targets the interleukin-6 (IL-6) receptor subunit, thereby inhibiting the IL-6/IL-6 receptor interaction.

Key Benefits & Uses

• Treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults
• Reduction of disease activity and frequency of relapses in NMOSD patients
• Improvement in quality of life for patients with NMOSD

Active Ingredient & Action

Satralizumab, the active ingredient in ENSPRYNG, works by binding to the IL-6 receptor subunit, thereby inhibiting the IL-6/IL-6 receptor interaction. This action reduces inflammation and prevents the activation of immune cells that contribute to the development of NMOSD.

Important Notes

ENSPRYNG is available by prescription only and should be used under the guidance of a healthcare professional. Patients with a history of severe hypersensitivity reactions to satralizumab or any component of the medication should not receive ENSPRYNG. Common side effects of ENSPRYNG include injection site reactions, headache, and upper respiratory tract infections.